ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors

相似書籍

• Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246)
  由: Walker, Alec, et al.
  出版: (2014)
• Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors
  由: Tschernia, Nicholas, et al.
  出版: (2014)
• Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase
  由: Walker, Alec J., et al.
  出版: (2017)
• Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma
  由: Zhongqing Zou, et al.
  出版: (2025-07-01)
• Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors
  由: Highfill, Steven L, et al.
  出版: (2013)